1,489 results on '"Young, Ken H."'
Search Results
2. Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients
3. DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma
4. Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
5. Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics
6. Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma
7. Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant
8. The Variability of the Black-Hole Image in M87 at the Dynamical Time Scale
9. Correction: Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma
10. The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma
11. Recent advances in genomics and therapeutics in mantle cell lymphoma
12. Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma
13. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL
14. Exome and targeted sequencing in clinical oncology—Use diffuse large B-cell lymphoma as a model in oncology practice
15. HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression
16. Detection of intrinsic source structure at ~3 Schwarzschild radii with Millimeter-VLBI observations of SAGITTARIUS A*
17. Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
18. Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features
19. A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform
20. Expanding anti-CD38 immunotherapy for lymphoid malignancies
21. RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics
22. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry
23. The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity
24. IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma
25. The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study
26. EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
27. Persistent Asymmetric Structure of Sagittarius A* on Event Horizon Scales
28. Resolved Magnetic-Field Structure and Variability Near the Event Horizon of Sagittarius A*
29. Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia
30. MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis
31. 230 GHz VLBI observations of M87: event-horizon-scale structure at the enhanced very-high-energy $\rm \gamma$-ray state in 2012
32. Vibrationally Excited C$_4$H
33. PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination
34. Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma
35. Minimal residual disease detection in lymphoma: methods, procedures and clinical significance.
36. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma
37. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP
38. Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
39. Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients
40. Risk of HBV reactivation post CD19-CAR-T cell therapy in DLBCL patients with concomitant chronic HBV infection
41. Fine-scale structure of the quasar 3C 279 Measured with 1.3 mm very long baseline interferometry
42. Cross-talk between Myc and p53 in B-cell lymphomas
43. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
44. Jet Launching Structure Resolved Near the Supermassive Black Hole in M87
45. Resolving the inner jet structure of 1924-292 with the EVENT HORIZON TELESCOPE
46. An Interferometric Spectral-line Survey of IRC+10216 in the 345 GHz Band
47. 1.3 mm Wavelength VLBI of Sagittarius A*: Detection of Time-Variable Emission on Event Horizon Scales
48. IRC+10216's Innermost Envelope -- The eSMA's View
49. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018–2022): A real‐world, retrospective study.
50. Tumor-infiltrating normal B cells revealed by immunoglobulin repertoire clonotype analysis are highly prognostic and crucial for antitumor immune responses in DLBCL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.